Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Moran

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Neoplasia (New York, N.Y.)|July 31, 2022
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)Lauren B Peiffer, James R White, Carli B Jones, et al.
Frontiers in Oncology|August 28, 2020
Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation TherapyJulie N Graff, Mark N Stein, Rishi Surana, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
IGF1 modulates lesional skin inflammation in checkpoint inhibitor-induced lichen planusNoah I Hornick, Avery Billo, Rosalyn M Fey, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Androgen receptor activity inversely correlates with immune cell infiltration and immunotherapy response across multiple cancer lineagesYa-Mei Hu, Faming Zhao, Julie N Graff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesionsLori J Wirth, Jeffrey F Krane, Yi Li, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progressionFaming Zhao, Jianming Zeng, Canping Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2018
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune ArthritisRuth J Napier, Ellen J Lee, Emily E Vance, et al.
Nature Biotechnology|November 12, 2021
Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing dataDuanchen Sun, Xiangnan Guan, Amy E Moran, et al.
Cancers|January 28, 2026
Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell CarcinomaWesley H Chou, Lucy Lawrence, Emma Neham, et al.
Nature|March 24, 2022
Androgen receptor activity in T cells limits checkpoint blockade efficacyXiangnan Guan, Fanny Polesso, Chaojie Wang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Neoplasia (New York, N.Y.)|July 31, 2022
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)Lauren B Peiffer, James R White, Carli B Jones, et al.
Frontiers in Oncology|August 28, 2020
Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation TherapyJulie N Graff, Mark N Stein, Rishi Surana, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
IGF1 modulates lesional skin inflammation in checkpoint inhibitor-induced lichen planusNoah I Hornick, Avery Billo, Rosalyn M Fey, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Androgen receptor activity inversely correlates with immune cell infiltration and immunotherapy response across multiple cancer lineagesYa-Mei Hu, Faming Zhao, Julie N Graff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesionsLori J Wirth, Jeffrey F Krane, Yi Li, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progressionFaming Zhao, Jianming Zeng, Canping Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2018
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune ArthritisRuth J Napier, Ellen J Lee, Emily E Vance, et al.
Nature Biotechnology|November 12, 2021
Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing dataDuanchen Sun, Xiangnan Guan, Amy E Moran, et al.
Cancers|January 28, 2026
Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell CarcinomaWesley H Chou, Lucy Lawrence, Emma Neham, et al.
Nature|March 24, 2022
Androgen receptor activity in T cells limits checkpoint blockade efficacyXiangnan Guan, Fanny Polesso, Chaojie Wang, et al.
Pageof 4